facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita has raised PLN 27.3 MM on its way to the main market of the Warsaw Stock Exchange

    Krakow, December 16 2014 - Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has successfully completed its Initial Public Offering. Gross proceeds from the sale of 2,651,891 new shares amount…

    Read More...

  • Felicitex Therapeutics and Selvita initiate strategic collaboration to target cancer quiescence

    Cambridge, MA and Krakow, Poland, 7 November 2014 - Felicitex Therapeutics, a leader in the diagnostics and development of therapeutics for quiescent cancers, and Selvita (PL: SLV), the largest drug discovery company in Central and Eastern Europe, an…

    Read More...

  • Selvita initiates cooperation with the Pharmaceutical Research Institute in the field of ophthalmic drug analysis

    Krakow, 09 October 2014 - Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has commenced a cooperation with the Pharmaceutical Research Institute from Warsaw, to provide the Institute with ser…

    Read More...